Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical characterization of children with monosymptomatic nocturnal enuresis: impact on efficacy of desmopressin and alarm therapy
2017-002169-23Phase 4Completed
- Sponsor
- Søren Rittig
- Start
- Jun 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of desmopressin in Monosymptomatic nocturnal enuresis (MNE) (2 arms), sponsored by Søren Rittig. Primary endpoint: Primary efficacy outcome. Started Jun 2017; status: completed.
02
Drugs
desmopressin
03
Conditions
Monosymptomatic nocturnal enuresis (MNE)
Beyond the preview
Go deeper on 2017-002169-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002169-23.